FDA.reportPublic FDA data

carbinoxamine maleate 1 MG/ML

RxCUI
1010977
RxNorm name
carbinoxamine maleate 1 MG/ML
Term type
SCDC
Status
Active
Updated
2026-06-12 06:59:54

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
1 MG / 1 MLcarbinoxamine

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
carbinoxamine20220

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
RXNAV_STRcarbinoxamine maleate 1 MG/MLNAMES
RxNorm Namecarbinoxamine maleate 1 MG/MLNAMES
TTYSCDCATTRIBUTES
RxCUI1010977CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCR06AAAminoalkyl ethersATC1-4carbinoxamine
FDASPLN0000175587Histamine-1 Receptor AntagonistEPChas_epccarbinoxamine
FDASPLN0000000190Histamine H1 Receptor AntagonistsMOAhas_moacarbinoxamine
MEDRTD011725PyridinesCHEMhas_ingredientcarbinoxamine maleate
MEDRTD011725PyridinesCHEMhas_ingredientcarbinoxamine
MEDRTD000799AngioedemaDISEASEmay_treatcarbinoxamine
MEDRTD000799AngioedemaDISEASEmay_treatcarbinoxamine maleate
MEDRTD001942Breast FeedingDISEASEci_withcarbinoxamine
MEDRTD001942Breast FeedingDISEASEci_withcarbinoxamine maleate
MEDRTD003233Conjunctivitis, AllergicDISEASEmay_treatcarbinoxamine
MEDRTD003233Conjunctivitis, AllergicDISEASEmay_treatcarbinoxamine maleate
MEDRTD003327Coronary DiseaseDISEASEci_withcarbinoxamine maleate
MEDRTD003327Coronary DiseaseDISEASEci_withcarbinoxamine
MEDRTD004342Drug HypersensitivityDISEASEci_withcarbinoxamine maleate
MEDRTD004342Drug HypersensitivityDISEASEci_withcarbinoxamine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withcarbinoxamine maleate
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withcarbinoxamine
MEDRTD006973HypertensionDISEASEci_withcarbinoxamine maleate
MEDRTD006973HypertensionDISEASEci_withcarbinoxamine
MEDRTD007231Infant, NewbornDISEASEci_withcarbinoxamine maleate
MEDRTD007231Infant, NewbornDISEASEci_withcarbinoxamine
MEDRTD007234Infant, PrematureDISEASEci_withcarbinoxamine maleate
MEDRTD007234Infant, PrematureDISEASEci_withcarbinoxamine
MEDRTD007415Intestinal ObstructionDISEASEci_withcarbinoxamine
MEDRTD007415Intestinal ObstructionDISEASEci_withcarbinoxamine maleate
MEDRTD010437Peptic UlcerDISEASEci_withcarbinoxamine
MEDRTD010437Peptic UlcerDISEASEci_withcarbinoxamine maleate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatcarbinoxamine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatcarbinoxamine maleate
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatcarbinoxamine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatcarbinoxamine maleate
MEDRTD013224Status AsthmaticusDISEASEci_withcarbinoxamine
MEDRTD013224Status AsthmaticusDISEASEci_withcarbinoxamine maleate
MEDRTD014517Ureteral ObstructionDISEASEci_withcarbinoxamine
MEDRTD014517Ureteral ObstructionDISEASEci_withcarbinoxamine maleate
MEDRTD014524Urethral ObstructionDISEASEci_withcarbinoxamine
MEDRTD014524Urethral ObstructionDISEASEci_withcarbinoxamine maleate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moacarbinoxamine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moacarbinoxamine maleate
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacarbinoxamine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacarbinoxamine maleate
MEDRTN0000008657Decreased Histamine ActivityPEhas_pecarbinoxamine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pecarbinoxamine maleate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYHYBRID
ATTRIBUTESIN_EXPRESSED_FLAGP
ATTRIBUTESSTRENGTH1 MG/ML
ATTRIBUTESTTYSCDC
CODESRxCUI1010977
NAMESRXNAV_STRcarbinoxamine maleate 1 MG/ML
NAMESRxNorm Namecarbinoxamine maleate 1 MG/ML